Is Anti-CD19 CAR T Cell therapy helpful in refractory SLE? The Visual Abract — NephJC
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis - The Lancet Haematology
CAR T-cell therapy in pediatrics
Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE) | BMJ Open
Treatment of aggressive lymphomas with anti-CD19 CAR T cells | Nature Reviews Clinical Oncology
CD19-targeted CAR T cells in refractory antisynthetase syndrome - The Lancet
Overview of CD19-targeted chimeric antigen receptor (CAR)-T-cell... | Download Scientific Diagram
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer: Molecular Therapy
Cells | Free Full-Text | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
FDA Approves Second CAR T-Cell Therapy - NCI
JCI - HIV-specific CAR T cells return to the clinic
Frontiers | Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells
The potential of CAR T therapy for relapsed or refractory pediatric an | TCRM
Frontiers | Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) - Sarah K. Tasian, Rebecca A. Gardner, 2015
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges - ScienceDirect
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant | Leukemia
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
